Pituitary ablation in diabetics with severe retinopathy.
Explore this paper's citation graph
Summary
Pituitary ablation seems to have inhibited the development of both retinopathy and iridic changes, but only long-term observations in controlled clinical trials can decide whether this operation is to have a permanent place in the treatment of diabetic Retinopathy.
- Type
- article
- Published
- 2009-04-24
- Cited by
- 6
- References
- 6
- OpenAlex
- https://openalex.org/W1972477359
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:44809471
Keywords
Medicine, Retinopathy, Diabetic retinopathy, Ablation, Ophthalmology
References
- Transsphenoidal hypophysectomy for diabetic retinopathy. Preliminary study of 18 cases.
- Diabetic retinopathy
- Pituitary ablation for diabetic retinopathy.
- Ophthalmological observations in hypophyseal stalk section. Report of 8 cases of advancing diabetic retinopathy.
- Hypophysectomy for diabetic angiopathy. A preliminary report.
- The use of hypophysectomy in juvenile diabetes mellitus with vascular complications.
Cited by
- Interstitial gamma irradiation by 198Au of the pituitary in diabetic retinopathy. Selective growth hormone blockade and ocular results.
- Ocular findings in 123 patients with proliferative diabetic retinopathy
- Classification of diabetic retinopathy, with therapeutic implications.
- Hypophysectomy for Diabetic Retinopathy During Pregnancy
- Growth hormone and ocular dysfunction: Endocrine, paracrine or autocrine etiologies?
- Ocular findings in 123 patients with proliferative diabetic retinopathy
Related papers
- Relationship Between Expression of NOS Subtypes and Retinal Blood Flow in Diabetic Rat Retina
- Prevalence of diabetic retinopathy at Parirenyatwa hospital
- The relationship of serum 8-hydroxydeoxyguanosin to diabetic retinopathy
- Spatial distribution of early red lesions is a risk factor for development of vision-threatening diabetic retinopathy
- Prevalence of Diabetic Retinopathy in Known Diabetics with Macrovascular Complications
- The relationship between the level of serum soluble CD40L and diabetic retinopathy